Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.

• Hilf N Immatics Biotechnologies GmbH, Tübingen, Germany.
• Kuttruff-Coqui S Immatics Biotechnologies GmbH, Tübingen, Germany.
• Frenzel K BioNTech AG, Mainz, Germany.
• Bukur V BioNTech AG, Mainz, Germany.
• Stevanović S Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Gouttefangeas C Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Platten M University Hospital Heidelberg, Heidelberg, Germany.
• Tabatabai G Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Dutoit V Geneva University Hospital, Geneva, Switzerland.
• van der Burg SH CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program, Mainz, Germany.
• Straten PT CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program, Mainz, Germany.
• Martinez-Ricarte F Vall d'Hebron University Hospital, Barcelona, Spain.
• Ponsati B BCN Peptides SA, Barcelona, Spain.
• Okada H University of California, San Francisco, San Francisco, CA, USA.
• Lassen U Ringhospitalet, Copenhagen, Denmark.
• Admon A Technion - Israel Institute of Technology, Haifa, Israel.
• Ottensmeier CH University of Southampton, Southampton, UK.
• Ulges A Immatics Biotechnologies GmbH, Tübingen, Germany.
• Kreiter S BioNTech AG, Mainz, Germany.
• von Deimling A University Hospital Heidelberg, Heidelberg, Germany.
• Skardelly M University Hospital Tübingen, Tübingen, Germany.
• Migliorini D Geneva University Hospital, Geneva, Switzerland.
• Kroep JR Leiden University Medical Center, Leiden, The Netherlands.
• Idorn M Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark.
• Rodon J Vall d'Hebron University Hospital, Barcelona, Spain.
• Piro J BCN Peptides SA, Barcelona, Spain.
• Poulsen HS Ringhospitalet, Copenhagen, Denmark.
• Shraibman B Technion - Israel Institute of Technology, Haifa, Israel.
• McCann K University of Southampton, Southampton, UK.
• Mendrzyk R Immatics Biotechnologies GmbH, Tübingen, Germany.
• Lower M BioNTech AG, Mainz, Germany.
• Stieglbauer M Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Britten CM BioNTech AG, Mainz, Germany.
• Capper D University Hospital Heidelberg, Heidelberg, Germany.
• Welters MJP CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program, Mainz, Germany.
• Sahuquillo J Vall d'Hebron University Hospital, Barcelona, Spain.
• Kiesel K Immatics Biotechnologies GmbH, Tübingen, Germany.
• Derhovanessian E BioNTech AG, Mainz, Germany.
• Rusch E Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Bunse L University Hospital Heidelberg, Heidelberg, Germany.
• Song C Immatics Biotechnologies GmbH, Tübingen, Germany.
• Heesch S BioNTech AG, Mainz, Germany.
• Wagner C Immatics Biotechnologies GmbH, Tübingen, Germany.
• Kemmer-Bruck A BioNTech AG, Mainz, Germany.
• Ludwig J Immatics Biotechnologies GmbH, Tübingen, Germany.
• Castle JC BioNTech AG, Mainz, Germany.
• Schoor O Immatics Biotechnologies GmbH, Tübingen, Germany.
• Tadmor AD TRON GmbH - Translational Oncology at the University Medical Center of Johannes Gutenberg University, Mainz, Germany.
• Green E German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.
• Fritsche J Immatics Biotechnologies GmbH, Tübingen, Germany.
• Meyer M Immatics Biotechnologies GmbH, Tübingen, Germany.
• Pawlowski N Immatics Biotechnologies GmbH, Tübingen, Germany.
• Dorner S Immatics Biotechnologies GmbH, Tübingen, Germany.
• Hoffgaard F Immatics Biotechnologies GmbH, Tübingen, Germany.
• Rossler B Immatics Biotechnologies GmbH, Tübingen, Germany.
• Maurer D Immatics Biotechnologies GmbH, Tübingen, Germany.
• Weinschenk T Immatics Biotechnologies GmbH, Tübingen, Germany.
• Reinhardt C Immatics Biotechnologies GmbH, Tübingen, Germany.
• Huber C BioNTech AG, Mainz, Germany.
• Rammensee HG Eberhard Karls Universität Tübingen, Tübingen, Germany.
• Singh-Jasuja H Immatics Biotechnologies GmbH, Tübingen, Germany.
• Sahin U BioNTech AG, Mainz, Germany.
• Dietrich PY Geneva University Hospital, Geneva, Switzerland.
• Wick W University Hospital Heidelberg, Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.

Multidisciplinary